...
首页> 外文期刊>Journal of Environmental Science and Technology >Sustainable Approach for Pharmaceutical Wastewater Treatment and Reuse: Case Study
【24h】

Sustainable Approach for Pharmaceutical Wastewater Treatment and Reuse: Case Study

机译:制药废水处理和回用的可持续方法:案例研究

获取原文
           

摘要

bBackground and Objectives:/b Pharmaceuticals and personal care products (PCP) are used to cure humans and animals. This industry consumes a huge amount of water during their manufacturing process. The wastewater discharged from it is contaminated by organic and in organic matter s which can be toxic to the ecosystem. The main goal of this study was the treatment of hazardous pharmaceutical wastewater containing low phenol content using activated sludge process (ASP) in combination with UV-free surface reactor process (UV-FSR) as a post treatment for disinfection. bMaterials and Methods:/b Environmental screening for the raw materials used in the manufacturing process at the pharmaceutical industry was investigated. Also, extensive physcio-chemical characterization for real pharmaceutical wastewater was carried out before and after each treatment step. Moreover, respiration activity test was done to investigate the toxicity of the raw pharmaceutical wastewater as well as the treated effluent using respiration activity method. Determination of the optimum operating conditions for the ASP and UV-FSR were achieved. bResults:/b The wastewater collected from the end-off-pipe were characterized by high organic loads represented by chemical and biological oxygen demands (COD, BODsub5/sub) and high content of total suspended solids (TSS). Their average values were 3200 mgOsub2/sub Lsup?/supsup1/sup, 1690 mgOsub2/sub Lsup?/supsup1/sup and 296 mg Lsup?/supsup1/sup, respectively; the main source of pollution comes from the syrup department. The wastewater contains three β-lactams antibiotics one belongs to cephalosporin (cephalexin and cefuroxime) while the other two belong to penicillin’s (ampicillin and amoxicillin) and other ingredients. However, operation of the ASP at a detention time of 6 h was capable for the degradation of the wastewater through sorption processes and hydroxylation. The average removal values of COD, BOD and TSS were 98.57, 98.99 and 98.31% with a residual value of 45.6, 17 and 5 mg O Lsup?/supsup1/sup, respectively. Furthermore, using UV-FSR for the elimination of Escherichia coli ( E. coli ), intestinal nematodes with the optimum UV-dose of 1.8 m Ws cmsup?/supsup2/sup was carried out. bConclusion:/b This treatment approach produces a good quality of treated effluent complying with the Egyptian code of practice (ECP 501/2015) for reuse in agricultural purposes.
机译:背景和目标:药品和个人护理产品(PCP)用于治疗人类和动物。这个行业在其制造过程中消耗大量的水。从其中排放的废水被有机物和有机物污染,这些有机物可能对生态系统有毒。这项研究的主要目标是使用活性污泥法(ASP)结合无紫外线的表面反应器法(UV-FSR)处理含酚量低的危险制药废水作为消毒的后处理。 材料和方法:对制药业生产过程中使用的原材料进行了环境筛选。同样,在每个处理步骤之前和之后,对实际制药废水进行了广泛的理化特性鉴定。此外,通过呼吸活性法进行了呼吸活性测试,以研究原料药废水和处理后废水的毒性。确定了ASP和UV-FSR的最佳操作条件。 结果:从尾管收集的废水的特点是有机负荷高,以化学和生物需氧量(COD,BOD 5 )表示,总含量高悬浮固体(TSS)。它们的平均值为3200 mgO 2 L ? 1 ,1690 mgO 2 L ? 1 和296 mg L ? 1 ;污染的主要来源来自糖浆部门。废水中含有三种β-内酰胺类抗生素,一种属于头孢菌素(头孢氨苄和头孢呋辛),另外两种则属于青霉素类(氨苄青霉素和阿莫西林)和其他成分。但是,ASP的滞留时间为6 h能够通过吸附过程和羟基化降解废水。 COD,BOD和TSS的平均去除率分别为98.57、98.99和98.31%,残留值为45.6、17和5 mg O L ? 1 。此外,使用UV-FSR消除大肠杆菌(E. coli),进行了最佳紫外线剂量为1.8 m Ws cm ? 2 的肠道线虫的研究。 。 结论:这种处理方法可产生符合埃及操作规范(ECP 501/2015)的优质处理废水,可用于农业用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号